Meridian Bioscience Inc. (VIVO)
NASDAQ: VIVO
· Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM
Meridian Bioscience Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 56.9M | 65.67M | 67.77M | 111.23M | 88.34M | 76.2M | 63.51M | 85.26M | 92.92M |
Cost of Revenue | 25.4M | 31.68M | 31.04M | 42.75M | 39.18M | 31.49M | 26.4M | 27.49M | 31.37M |
Gross Profit | 31.5M | 33.99M | 36.73M | 68.48M | 49.16M | 44.72M | 37.11M | 57.77M | 61.55M |
Operating Income | -28.95M | 4.85M | -6.35M | 36.88M | 20.12M | 8.49M | 15.68M | 34.2M | 34.66M |
Interest Income | 3K | 12K | 2K | 2K | 1K | -15K | n/a | 6K | 9K |
Pretax Income | -29.1M | 4.63M | -6.6M | 36.53M | 19.75M | 7.86M | 15.29M | 33.05M | 34.25M |
Net Income | -29.82M | 5.71M | -7.34M | 28.75M | 15.34M | 6.66M | 11.67M | 26.3M | 26.78M |
Selling & General & Admin | 19.37M | 18.62M | 21.33M | 26.58M | 22.68M | 19.83M | 18.61M | 20.5M | 11.94M |
Research & Development | 6.18M | 6.41M | 6.04M | 5.69M | 6.19M | 6.11M | 6.08M | 6.07M | 5.65M |
Other Expenses | 8.68M | -350K | n/a | n/a | 281K | 5.6M | n/a | -200K | 9.29M |
Operating Expenses | 34.22M | 24.68M | 27.37M | 32.27M | 28.88M | 31.54M | 24.69M | 26.36M | 26.88M |
Interest Expense | 148K | 220K | 256K | 341K | 372K | 428K | 444K | 472K | 534K |
Selling & Marketing Expenses | 8.29M | 7.84M | 8.18M | 7.51M | 7.74M | 7.01M | 6.21M | 6.54M | 7.02M |
Cost & Expenses | 59.62M | 56.36M | 58.41M | 75.02M | 68.06M | 63.03M | 51.09M | 53.85M | 58.25M |
Income Tax Expense | 724K | -1.07M | 736K | 7.78M | 4.41M | 1.2M | 3.63M | 6.75M | 7.47K |
Shares Outstanding (Basic) | 43.9M | 44.73M | 44.47M | 44.26M | 43.44M | 43.36M | 43.33M | 43.24M | 43.1M |
Shares Outstanding (Diluted) | 43.9M | 44.73M | 44.47M | 44.26M | 44.03M | 44.09M | 44.1M | 44.12M | 43.78M |
EPS (Basic) | -0.68 | 0.13 | -0.16 | 0.65 | 0.35 | 0.15 | 0.27 | 0.61 | 0.62 |
EPS (Diluted) | -0.68 | 0.13 | -0.16 | 0.65 | 0.35 | 0.15 | 0.26 | 0.60 | 0.61 |
EBITDA | -28.11M | 8.92M | -2.24M | 41.03M | 24.31M | 12.39M | 19.49M | 37.23M | 34.66M |
EBIT | -28.95M | 4.85M | -6.01M | 36.88M | 20.12M | 8.28M | 15.74M | 33.52M | 34.78M |
Depreciation & Amortization | 4.18M | 4.07M | 4.11M | 4.15M | 4.18M | 4.1M | 3.75M | 3.71M | 1.51M |